Balancing hormonal shifts: exploring the impact of ageing and dietary restriction [0.03%]
激素波动的平衡：探究衰老与饮食限制的影响
Stephen M Twigg,Luigi Fontana
Stephen M Twigg
A letter to my GP [0.03%]
致我的家庭医生的一封信
Jessica Catchpole
Jessica Catchpole
Explaining the high rate of progression from prediabetes to type 2 diabetes in China [0.03%]
解析中国从前期糖尿病进展到2型糖尿病的高发病率的原因
Natural Chu,Jie He,Kathy H T Leung et al.
Natural Chu et al.
Explaining the high rate of progression from prediabetes to type 2 diabetes in China - Authors' reply [0.03%]
对中国从前期糖尿病进展到2型糖尿病的速度较快的解释-作者回应
Lihui Zhang,Qiuhong Gong,Ningling Sun et al.
Lihui Zhang et al.
Neena Prasad,J Jaime Miranda
Neena Prasad
Glycaemic fluctuations across the menstrual cycle: possible effect of the brain [0.03%]
月经周期中的血糖波动：可能的脑部效应
Julia Hummel,Stephanie Kullmann,Róbert Wagner et al.
Julia Hummel et al.
Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease [0.03%]
贯穿一生的性激素与女性大脑：抑郁症和阿尔茨海默病发病风险的新见解
Claudia Barth,Arielle Crestol,Ann-Marie G de Lange et al.
Claudia Barth et al.
Despite widespread sex differences in prevalence and presentation of numerous illnesses affecting the human brain, there has been little focus on the effect of endocrine ageing. Most preclinical studies have focused on males only, and clini...
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial [0.03%]
住院COVID-19患者使用恩格列净治疗研究（RECOVERY）：一项随机、对照、开放标签平台试验
RECOVERY Collaborative Group
RECOVERY Collaborative Group
Background: Empagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic, and haemodynamic effects. The RECOVERY trial aimed to assess its safety and efficacy in patients ad...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2023 Dec;11(12):905-914. DOI:10.1016/S2213-8587(23)00253-X 2023